- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: International journal of legal medicine, 135.2021, 5, S. 2055-2060
- Event
-
Veröffentlichung
- (where)
-
Frankfurt am Main
- (who)
-
Universitätsbibliothek Johann Christian Senckenberg
- (when)
-
2021
- DOI
-
10.1007/s00414-021-02546-7
- URN
-
urn:nbn:de:hebis:30:3-692336
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:51 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Plenzig, Stefanie
- Bojkova, Denisa
- Held, Hannelore
- Berger, Annemarie
- Holz, Franziska
- Cinatl, Jindrich
- Gradhand, Elise
- Kettner, Matthias
- Pfeiffer, Annika
- Verhoff, Marcel A.
- Ciesek, Sandra
- Universitätsbibliothek Johann Christian Senckenberg
Time of origin
- 2021
Other Objects (12)
Phänotyp und Funktion humaner CD1c-positiver dendritischer Zellen : Bedeutung für die Hepatitis-C-Virus-Infektion
Die Entwicklung von Zellkulturen in proteinfreien chemisch volldefinierten Medien : Perspektiven für die Virologie und Biotechnologie
COVID-19-related coagulopathy - is transferrin a missing link?
Targeting pentose phosphate pathway for SARS-CoV-2 therapy
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
Growth factor receptor signaling inhibition prevents SARS-CoV-2 replication
Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings
Lack of antiviral activity of darunavir against SARS-CoV-2
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
Development of antiviral strategies against positive-sense single stranded RNA viruses
Phänotyp und Funktion humaner CD1c-positiver dendritischer Zellen : Bedeutung für die Hepatitis-C-Virus-Infektion
Die Entwicklung von Zellkulturen in proteinfreien chemisch volldefinierten Medien : Perspektiven für die Virologie und Biotechnologie
COVID-19-related coagulopathy - is transferrin a missing link?
Targeting pentose phosphate pathway for SARS-CoV-2 therapy
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
Growth factor receptor signaling inhibition prevents SARS-CoV-2 replication
Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings
Lack of antiviral activity of darunavir against SARS-CoV-2
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
Development of antiviral strategies against positive-sense single stranded RNA viruses
Phänotyp und Funktion humaner CD1c-positiver dendritischer Zellen : Bedeutung für die Hepatitis-C-Virus-Infektion
Die Entwicklung von Zellkulturen in proteinfreien chemisch volldefinierten Medien : Perspektiven für die Virologie und Biotechnologie
COVID-19-related coagulopathy - is transferrin a missing link?
Targeting pentose phosphate pathway for SARS-CoV-2 therapy
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
Growth factor receptor signaling inhibition prevents SARS-CoV-2 replication
Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings
Lack of antiviral activity of darunavir against SARS-CoV-2
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants